Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
UBS
Citi
QuintilesIMS
AstraZeneca
Novartis
Deloitte
McKinsey
Healthtrust
Teva

Generated: August 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074243

« Back to Dashboard
NDA 074243 describes LORAZEPAM, which is a drug marketed by Hospira, Leading Pharma Llc, Lupin Ltd, Watson Labs, Sagent Agila Llc, Akorn, Amneal Pharms, Am Therap, Halsey, Watson Labs Inc, Warner Chilcott, Usl Pharma, Sandoz, Paddock Llc, Sun Pharm Inds Ltd, Superpharm, Roxane, Intl Medication Sys, Frontida Biopharm, Vintage Pharms, Mylan, Pharm Assoc, Hi-tech Pharma Co, Mutual Pharm, Par Pharm, Bedford, Dava Pharms Inc, West-ward Pharms Int, Ani Pharms Inc, and Bedford Labs, and is included in sixty-seven NDAs. It is available from fifty-two suppliers. Additional details are available on the LORAZEPAM profile page.

The generic ingredient in LORAZEPAM is lorazepam. There are eleven drug master file entries for this compound. Fifty-five suppliers are listed for this compound. Additional details are available on the lorazepam profile page.

Summary for NDA: 074243

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 074243

Ingredient-typeBenzodiazepines

Suppliers and Packaging for NDA: 074243

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LORAZEPAM
lorazepam
INJECTABLE;INJECTION 074243 ANDA Hospira, Inc. 0409-1539 0409-1539-31 10 CARTRIDGE in 1 BOX (0409-1539-31) > 1 mL in 1 CARTRIDGE
LORAZEPAM
lorazepam
INJECTABLE;INJECTION 074243 ANDA Hospira, Inc. 0409-1985 0409-1985-30 10 CARTRIDGE in 1 BOX (0409-1985-30) > 1 mL in 1 CARTRIDGE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength2MG/ML
Approval Date:Apr 12, 1994TE:APRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength4MG/ML
Approval Date:Apr 12, 1994TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
QuintilesIMS
Novartis
Merck
Cantor Fitzgerald
Fish and Richardson
Cipla
Federal Trade Commission
US Department of Justice
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot